Section of Oral Health and Periodontology, Division of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, Alfred Nobels alle 8, 141 52, Huddinge, Stockholm, Sweden.
Clin Oral Investig. 2023 Mar;27(3):971-978. doi: 10.1007/s00784-023-04878-7. Epub 2023 Feb 1.
The interface of molecular science and technology is guiding the transformation of personalized to precision healthcare. The application of proteomics, genomics, transcriptomics, and metabolomics is shaping the suitability of biomarkers for disease. Prior validation of such biomarkers in large and diverse patient cohorts helps verify their clinical usability. Incorporation of molecular discoveries into routine clinical practice relies on the development of customized assays and devices that enable the rapid delivery of analytical data to the clinician, while the patient is still in session. The present perspective review addresses this topic under the prism of precision periodontal care. Selected promising research attempts to innovate technological platforms for oral diagnostics are brought forward. Focus is placed on (a) the suitability of saliva as a conveniently sampled biological specimen for assessing periodontal health, (b) proteomics as a high-throughput approach for periodontal disease biomarker identification, and (c) chairside molecular diagnostic assays as a technological funnel for transitioning from the laboratory benchtop to the clinical point-of-care.
分子科学与技术的界面正在引导个性化向精准医疗的转变。蛋白质组学、基因组学、转录组学和代谢组学的应用正在塑造疾病生物标志物的适用性。在大型和多样化的患者队列中对这些生物标志物进行预先验证有助于验证其临床可用性。将分子发现纳入常规临床实践依赖于开发定制的检测和设备,这些检测和设备能够将分析数据快速提供给临床医生,而患者仍在就诊中。本观点综述从精准牙周护理的角度探讨了这一主题。提出了一些有前景的研究尝试,旨在创新口腔诊断的技术平台。重点放在:(a) 唾液作为评估牙周健康的便利样本的适用性,(b) 蛋白质组学作为牙周病生物标志物鉴定的高通量方法,以及 (c) 椅旁分子诊断检测作为从实验室台式机到临床床边的技术渠道。